Billion

<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div>
<p class="has-drop-cap">Science Applications International Corporation (<a href="https://investors.saic.com/press-releases/press-release-details/2024/SAIC-Announces-Fourth-Quarter-and-Full-Fiscal-Year-2024-Results/default.aspx" target="_blank" aria-label="NASDAQ: SAIC (opens in a new tab)" rel="noopener noreferrer nofollow" class="deco-link">NASDAQ: SAIC</a>) has unveiled its results for the fourth quarter and the full fiscal year 2024, marking significant achievements and setting a solid foundation for future growth. <br><br>The company reported Q4 FY24 revenues of $1.74 billion, exhibiting a 7.7% organic growth, and full-year revenue of $7.44 billion, indicating a 7.4% organic growth.</p>
<p>This growth reflects SAIC’s strategic divestitures and the extra working days in the previous year. The company’s net income was $39 million for the quarter, with an adjusted EBITDA of $127 million, or 7.3% of revenue. <br><br>The full year saw net income of $477 million and adjusted EBITDA of $668 million or 9.0% of revenue, factors impacted by higher incentive-based compensation. SAIC’s diluted <a href="https://tokenist.com/investing/how-to-value-a-stock/" rel="noopener noreferrer nofollow" class="deco-link">earnings per share</a> for Q4 FY24 were $0.74, with an adjusted diluted earnings per share of $1.43. The company also reported strong cash flow, with $63 million provided by operating activities in Q4 and $396 million for the full fiscal year.</p>
<h3 id="science-applications-misses-out-on-q4-eps-by-0-01">Science Applications Misses Out on Q4 EPS by $0.01</h3>
<p>When compared against the expectations, SAIC’s performance in Q4 FY24 has outperformed the projected metrics. Analysts had anticipated an EPS of $1.44 and revenue of $1.64 billion for the quarter. SAIC’s reported revenue of $1.74 billion surpassed these expectations, showcasing the company’s capability to drive growth and exceed market predictions. <br><br>The adjusted diluted earnings per share of $1.43 were slightly under the anticipated EPS, missing it by $0.01, but reflected the company’s strategic financial management and its impacts from higher compensation expenses.</p>
<div class="cta-referral"><img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async">
 <div class="cta-referral__text">
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking story.</a></p>
 </div>
</div>
<h3 id="saic-excepts-adjusted-ebitda-for-2025-to-be-between-680-million-and-700-million">SAIC Excepts Adjusted EBITDA for 2025 to be Between $680 million and $700 million</h3>
<p>SAIC has updated its fiscal year 2025 guidance to reflect an optimistic outlook based on the company’s current performance trajectory and market opportunities. The company anticipates revenues to be between $7.35 billion and $7.50 billion, with adjusted EBITDA expected to be between $680 million to $700 million. <br><br>The adjusted EBITDA margin percentages are forecasted to be between 9.2% and 9.4%, with adjusted diluted EPS projected to remain within the $8.00 to $8.20 range. Free cash flow expectations have been adjusted to range between $490 million and $510 million, highlighting SAIC’s focus on sustaining its financial health and investing in strategic growth areas.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe>
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p>
<h3 id="br"><br></h3>
<p>The post <a rel="noopener noreferrer nofollow" href="https://tokenist.com/science-applications-international-reports-7-4-organic-growth-sets-7-5-billion-revenue-target-for-fy25/">Science Applications International Reports 7.4% Organic Growth, Sets $7.5 Billion Revenue Target for FY25</a> appeared first on <a rel="noopener noreferrer nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Science Applications International Reports 7.4% Organic Growth, Sets $7.5 Billion Revenue Target for FY25

Table of Contents

Tokenist

Other articles published on Mar 18, 2024

Solana Achieves $200 Milestone! Correction Impending For SOL Price?

Analyst predicts 70% surge for Solana, Is SOL set for another record high?

Standard Chartered Predicts Bitcoin At $150,000, ETH At $8,000 By Year-End

New and Best Meme Coins To Buy Sunday, March 17 – Book of Meme, DogeDash, Brett, Sponge V2

BOME Price Prediction:Is BOME Set to Resume Bullish Momentum

Crypto Catalysts: The Events Propelling Altcoins to New Heights

Join our free newsletter for daily crypto updates!